Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

GrafTech International Ltd (NYSE:GTI) is a $1.55 billion market cap manufacturer of a range of high quality graphite electrodes, products essential to the production of electric arc furnace steel and various other ferrous and nonferrous metals. After the company reported earnings on April 24, despite beating analyst estimates and proving bears wrong, the stock price still edged down. Amidst this unusual situation, several insiders took advantage of this to raise their exposure.

On April 25, Mary Cranston, Board Director, acquired 22,100 shares for $11.37 each, and now holds 79,040 shares (of which 77,040 are held directly, and another 2,000, through a trust). On that same date, three more Board Directors bought GrafTech’s stock.

A few days later, on April 28, Randy Carson, another Board Director, acquired 13,480 GrafTech shares for $11.72 per share. He currently owns 73,388 shares of the company.

In addition to these insiders, several hedge funds are betting on this stock. As we reported a month ago, a few of them recently added GrafTech to their equity portfolios. This is the case of Peter Schliemann‘s Rutabaga Capital Management, Peter Muller´s PDT Partners and Israel Englander‘s Millennium Management, who bought 2.47 million shares, 258,589 shares, and 249,295 shares, respectively.

All of this bullishness can be understood only if one analyzes GrafTech’s growth prospects. Analysts expect it to outperform its peers over the long-term, delivering average annual EPS growth rates around 18%. For the shorter term, EPS growth is expected to come in at 87.50% this year, and 233.30% next year, mainly driven by a rationalization plan that aims to achieve $75 million of annual cost savings. This kind of growth potential coupled with a below-average valuation (1.1x P/S and 1.3x P/B), make of this stock an attractive investment option. With both insiders and major funds betting on this stock, it might be a time to buy.